Breakthru Medicine develops targeted cancer therapies using small molecules, molecular glues and new antibody-drug conjugate payloads.
Startup Funding News
New startup rounds, lead investors and the businesses behind the funding.
1 round · $60M disclosed · $60M median
| Company | Amount | Stage / sector | Lead investor | Announced |
|---|---|---|---|---|
| Breakthru Medicine Breakthru Medicine develops targeted cancer therapies using small molecules, molecular glues and new antibody-drug conjugate payloads. | $60M | Series A Biotechnology | — |
02 / Perspective
Reports & briefings
monthly briefing
September 2026 Startup Funding Report
74 sourced rounds, with company profiles and participating investors.
weekly briefing
Sep 21 – 27, 2026 Startup Funding Weekly
27 sourced rounds, with company profiles and participating investors.
weekly briefing
Sep 14 – 20, 2026 Startup Funding Weekly
5 sourced rounds, with company profiles and participating investors.
03 / Investors
Active investors
| Investor | Rounds | Led | Recent investments |
|---|---|---|---|
| 01Lightspeed Venture Partners | 22 | 5 | Temporal TechnologiesNeko Health |
| 02Andreessen Horowitz | 21 | 7 | ArmadinEliseAI |
| 03Index Ventures | 20 | 6 | Temporal TechnologiesMistral AI |
| 04General Catalyst | 20 | 1 | General IntuitionDwelly |